Search results
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 18 hours agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
COVID Vaccine Side Effects: 4 Takeaways From Our Investigation
The New York Times via Yahoo News· 9 hours agoSoon after their arrival in late December 2020, the COVID-19 vaccines turned the pandemic around and...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 2 days agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 3 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 1 day agoModerna added that clinical development and manufacturing expenses also decreased, driven by lower...
TIME100 Health: Katalin Kariko and Drew Weissman
Time via Yahoo News· 2 days agoIn under a year, both Pfizer-BioNTech and Moderna developed mRNA-based COVID-19 vaccines based ...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 3 days agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed ...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 5 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
The CDC Took Out 148 Pages of Essential Information
Mercola· 1 day agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of ...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 2 days agoLitigation and Intellectual Property Updates Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/& ...